Caracteristics | Percentage (%) | |
---|---|---|
Age at surgery | ||
40–50 | 3.9 | [n = 4] |
50–60 | 16.7 | [n = 17] |
60–70 | 31.4 | [n = 32] |
70–80 | 40.2 | [n = 41] |
>80 | 7.8 | [n = 8] |
Gender | ||
Male | 54.9 | [n = 56] |
Female | 45.1 | [n = 46] |
Stagea | ||
0 | 2.0 | [n = 2] |
IA | 4.0 | [n = 4] |
IB | 7.8 | [n = 8] |
IIA | 31.4 | [n = 32] |
IIB | 47.9 | [n = 49] |
III | 2.9 | [n = 3] |
IV | 4.0 | [n = 4] |
Primary tumora | ||
Tis | 2.0 | [n = 2] |
T1 | 6.0 | [n = 6] |
T2 | 14.5 | [n = 15] |
T3 | 75.5 | [n = 77] |
T4 | 2.0 | [n = 2] |
Regional lymph nodesa | ||
N0 | 46.1 | [n = 47] |
N1 | 53.9 | [n = 55] |
M0 | 96.1 | [n = 98] |
M1 | 3.9 | [n = 4] |
Histologyb | ||
PanIN | 2.0 | [n = 2] |
well | 30.4 | [n = 31] |
moderate | 55.8 | [n = 57] |
poor | 11.8 | [n = 12] |
Venous invasionb | ||
v0 | 55.4 | [n = 57] |
v1 | 30.7 | [n = 31] |
v2 | 10.9 | [n = 11] |
v3 | 3.0 | [n = 3] |
Lymphatic invasionb | ||
ly0 | 42.6 | [n = 43] |
ly1 | 33.6 | [n = 34] |
ly2 | 19.9 | [n = 21] |
ly3 | 3.9 | [n = 4] |
CCDC88A expression | ||
Low | 75.5 | [n = 77] |
High | 24.5 | [n = 25] |